Sold as Quinidine Gluconate, Quinaglute, Duraquin. Every FDA application for this active ingredient: 3 branded and 13 generic.
As of Nov 15, 2026, FDA lists 16 applications for Quinidine Gluconate (sold as Quinidine Gluconate, Quinaglute, Duraquin), first approved Jul 12, 1950, with 1 new use approved and 0 published complete response letters.
| Product | Part | Spending, 2025 | Change | Beneficiaries |
|---|---|---|---|---|
| Quinidine Gluconate | Part D | $1.3M | -1% | 472 |
| Jul 12, 1950 | Quinidine GluconateNDA 7529 · New active ingredient | Lilly | 13 | Discontinued |
| Dec 8, 1969 | QuinagluteNDA 16647 · New dosage form | Bayer Hlthcare | 31 | Discontinued |
| Nov 20, 1981 | QuinatimeANDA 87448 | Watson Labs | 1 | Discontinued |
| Sep 29, 1982 | Quinidine GluconateANDA 87810 | Ani Pharms | 14 | Discontinued |
| Jan 24, 1983 | Quinidine GluconateANDA 87785 | Watson Labs | 0 | Discontinued |
| Jan 6, 1984 | Quinidine GluconateANDA 88431 | Cycle | 0 | Discontinued |
| Feb 10, 1986 | QuinalanANDA 88081 | Chartwell Molecular | 0 | Discontinued |
| Feb 11, 1987 | Quinidine GluconateANDA 89338 | Sun Pharm Industries | 21 | Marketed |
| Dec 15, 1988 | Quinidine GluconateANDA 89894 | Rising | 6 | Discontinued |
| Sep 17, 2021 | Quinidine GluconateANDA 212589 | Adaptis | 1 | Marketed |
| — | QuinactANDA 85978 | Bayer Hlthcare | 0 | Discontinued |
| — | QuinactANDA 86099 | Bayer Hlthcare | 0 | Discontinued |
| — | Quinidine GluconateANDA 88582 | Ascot | 0 | Discontinued |
| — | Quinidine GluconateANDA 89164 | Superpharm | 0 | Discontinued |
| — | Quinidine GluconateANDA 89476 | Halsey | 0 | Discontinued |
| — | DuraquinNDA 17917 | Warner Chilcott | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA